Vincent J. Angotti Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Vincent J. Angotti.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Vincent J. Angotti. Vincent J. Angotti is Chief Executive Officer in ACELRX PHARMACEUTICALS INC ($ACRX).
Latest Insider Trading Transactions of Vincent J. Angotti
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 05 2021 | ACRX | ACELRX PHARMACEUTI ... | Angotti Vincent J. | Chief Executive Off ... | Option Exercise | A | 1.88 | 1,000,000 | 1,880,000 | 1,000,000 | |
Mar 05 2021 | ACRX | ACELRX PHARMACEUTI ... | Angotti Vincent J. | Chief Executive Off ... | Grant | A | 0.00 | 200,000 | 0 | 636,980 | 437 K to 637 K (+45.77 %) |
Feb 12 2021 | ACRX | ACELRX PHARMACEUTI ... | Angotti Vincent J. | Chief Executive Off ... | Payment of Exercise | F | 2.63 | 23,052 | 60,627 | 427,887 | 450.9 K to 427.9 K (-5.11 %) |
Feb 09 2021 | ACRX | ACELRX PHARMACEUTI ... | Angotti Vincent J. | Chief Executive Off ... | Payment of Exercise | F | 2.59 | 25,059 | 64,903 | 450,939 | 476 K to 450.9 K (-5.26 %) |
Jun 15 2020 | ACRX | ACELRX PHARMACEUTI ... | Angotti Vincent J. | Chief Executive Off ... | Buy | P | 1.33 | 7,547 | 10,035 | 468,757 | 461.2 K to 468.8 K (+1.64 %) |
Feb 13 2020 | ACRX | ACELRX PHARMACEUTI ... | Angotti Vincent J. | Chief Executive Off ... | Payment of Exercise | F | 1.71 | 23,052 | 39,419 | 452,892 | 475.9 K to 452.9 K (-4.84 %) |
Feb 07 2020 | ACRX | ACELRX PHARMACEUTI ... | Angotti Vincent J. | Chief Executive Off ... | Option Exercise | A | 1.72 | 400,000 | 688,000 | 400,000 | |
Feb 07 2020 | ACRX | ACELRX PHARMACEUTI ... | Angotti Vincent J. | Chief Executive Off ... | Grant | A | 0.00 | 200,000 | 0 | 475,944 | 275.9 K to 475.9 K (+72.48 %) |
Nov 12 2019 | ACRX | ACELRX PHARMACEUTI ... | Angotti Vincent J. | Chief Executive Off ... | Buy | P | 1.79 | 8,379 | 14,973 | 275,944 | 267.6 K to 275.9 K (+3.13 %) |
Nov 04 2019 | ACRX | ACELRX PHARMACEUTI ... | Angotti Vincent J. | Chief Executive Off ... | Option Exercise | A | 2.23 | 96,250 | 214,156 | 192,500 | |
Jun 06 2019 | ACRX | ACELRX PHARMACEUTI ... | Angotti Vincent J. | Chief Executive Off ... | Buy | P | 2.31 | 5,000 | 11,550 | 262,884 | 257.9 K to 262.9 K (+1.94 %) |
Mar 04 2019 | ACRX | ACELRX PHARMACEUTI ... | Angotti Vincent J. | Chief Executive Off ... | Buy | P | 2.81 | 3,234 | 9,088 | 257,884 | 254.7 K to 257.9 K (+1.27 %) |
Feb 13 2019 | ACRX | ACELRX PHARMACEUTI ... | Angotti Vincent J. | Chief Executive Off ... | Option Exercise | A | 2.51 | 400,000 | 1,004,000 | 400,000 | |
Feb 13 2019 | ACRX | ACELRX PHARMACEUTI ... | Angotti Vincent J. | Chief Executive Off ... | Grant | A | 0.00 | 200,000 | 0 | 254,650 | 54.7 K to 254.7 K (+365.97 %) |
Dec 17 2018 | ACRX | ACELRX PHARMACEUTI ... | Angotti Vincent J. | Chief Executive Off ... | Buy | P | 2.78 | 3,610 | 10,024 | 54,650 | 51 K to 54.7 K (+7.07 %) |
Dec 12 2018 | ACRX | ACELRX PHARMACEUTI ... | Angotti Vincent J. | Chief Executive Off ... | Buy | P | 2.99 | 10,000 | 29,890 | 51,040 | 41 K to 51 K (+24.37 %) |
Nov 05 2018 | ACRX | ACELRX PHARMACEUTI ... | Angotti Vincent J. | Chief Executive Off ... | Option Exercise | A | 2.23 | 96,250 | 214,156 | 96,250 | |
Sep 05 2018 | ACRX | ACELRX PHARMACEUTI ... | Angotti Vincent J. | Chief Executive Off ... | Grant | A | 1.49 | 6,040 | 9,000 | 41,040 | 35 K to 41 K (+17.26 %) |
Aug 07 2018 | ACRX | ACELRX PHARMACEUTI ... | Angotti Vincent J. | Chief Executive Off ... | Buy | P | 2.90 | 10,000 | 28,950 | 35,000 | 25 K to 35 K (+40.00 %) |
Jan 26 2018 | ACRX | ACELRX PHARMACEUTI ... | Angotti Vincent J. | Chief Executive Off ... | Option Exercise | A | 2.00 | 350,000 | 700,000 | 350,000 | |
Jan 26 2018 | ACRX | ACELRX PHARMACEUTI ... | Angotti Vincent J. | Chief Executive Off ... | Option Exercise | A | 2.00 | 350,000 | 700,000 | 350,000 | |
Aug 24 2017 | ACRX | ACELRX PHARMACEUTI ... | Angotti Vincent J. | Chief Executive Off ... | Buy | P | 3.00 | 15,000 | 45,000 | 15,000 | 0 to 15 K |
Mar 07 2017 | ACRX | ACELRX PHARMACEUTI ... | Angotti Vincent J. | Chief Executive Off ... | Option Exercise | A | 3.30 | 800,000 | 2,640,000 | 800,000 |
Page: 1